Several genetic, cell biology, biochemical and animal studies supported that inhibiting NF-κB could play a critical role in preventing the development of AD pathology (Selkoe, 2001; Ghiso and Frangione, 2002). This evidence concerns the gene NFKB1 and Alzheimer disease.